FDA Approves Benlysta Autoinjector for Pediatric Patients With Active Lupus Nephritis
Benlysta is the first and only approved autoinjector biologic for both systemic lupus erythematosus and lupus nephritisContinue Reading
Benlysta is the first and only approved autoinjector biologic for both systemic lupus erythematosus and lupus nephritisContinue Reading
MONDAY, June 16, 2025 (HealthDay News) — Kidney damage is common during a severe case of COVID-19, but vaccination appears to protect people against this life-threatening side effect, a new study says. Unvaccinated COVID patients with kidney damage severe enough to require dialysis are nearly three times as likely toContinue Reading
MONDAY, June 9, 2025 (HealthDay News) — Prompt treatment with a drug combo can effectively manage chronic kidney disease in people with type 2 diabetes, a new clinical trial shows. Patients prescribed the combination of finerenone and empagliflozin experienced a 52% decrease in their urinary albumin-to-creatinine ratio, researchers report inContinue Reading
THURSDAY, May 8, 2025 (HealthDay News) — Wearing a face mask to protect others from infectious disease continues to be hotly debated in the United States. But what about wearing a face mask to detect chronic kidney disease? A modified surgical face mask containing a specialized breath sensor can accuratelyContinue Reading
WEDNESDAY, April 16, 2025 (HealthDay News) — A new clinical trial will soon test if a pig liver can help people whose own livers have suddenly stopped working. The hope? That animal organs can temporarily filter a patient’s blood, giving their own liver time to rest and possibly recover. TheContinue Reading
THURSDAY, March 6, 2025 (HealthDay News) — GLP-1 drugs like Ozempic can help kidney transplant patients avoid organ failure and live longer, a new study suggests. The drugs help manage patients’ type 2 diabetes and promote weight loss, both of which improve the chances of a successful kidney transplant, researchersContinue Reading
FRIDAY, Feb. 21, 2025 (HealthDay News) — The health benefits of aggressive blood pressure control outweigh the potential risks for seniors, according to the latest results from a major clinical trial. About 85% of seniors treated to a target blood pressure of 120 systolic (the top number in a bloodContinue Reading
TUESDAY, Feb. 11, 2025 (HealthDay News) — Ozempic, Wegovy, Saxenda, Trulicity: These and other GLP1-RA diabetes/weight-loss meds can also boost outcomes for folks battling chronic kidney disease, new research shows. Compared to another common class of kidney medications, called DPP4is, GLP1-RA medications did better in helping slow the progression ofContinue Reading
TUESDAY, Nov. 26, 2024 (HealthDay News) — The potential health benefits of GLP-1 diabetes and weight loss meds keep piling up: New research shows they may also shield your kidneys from harm. In the largest study to date on the effects of the drugs on the kidneys, researchers found GLP-1sContinue Reading
MONDAY, Nov. 11, 2024 (HealthDay News) — People with both type 2 diabetes and chronic kidney disease face a heart health double-whammy, a new study says. Men with both diabetes and kidney disease will develop heart health problems 28 years earlier than those without either condition, researchers reported today atContinue Reading
© 2021 WeeklyMD.com - All Rights Reserved.